Hepatosplenic T cell lymphoma medical therapy: Difference between revisions
No edit summary |
Mahshid |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatosplenic T cell lymphoma}} | {{Hepatosplenic T cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | |||
==Overview== | |||
The predominant therapy for hepatosplenic T cell lymphoma is [[chemotherapy]]. Adjunctive stem cell transplant may be required. | |||
==Medical Therapy== | |||
The predominant therapy for hepatosplenic T cell lymphoma is [[chemotherapy]]. Adjunctive stem cell transplant may be required. | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+ '''Treatment of hepatosplenic T cell lymphoma<ref name= canadiancancer>Hepatosplenic T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/hepatosplenic-t-cell-lymphoma/?region=nb. Accessed on February 23, 2016 </ref>''' | |||
! style="background: #4479BA; color:#FFF;" | Therapy | |||
! style="background: #4479BA; color:#FFF;" | Description | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | Chemotherapy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Most often, patients with hepatosplenic T cell lymphoma are treated with combination chemotherapy | |||
* Drug regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | Stem cell transplant | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* A stem cell transplant may be an option for some patients with hepatosplenic T cell lymphoma | |||
|} | |||
==References== | ==References== | ||
| Line 12: | Line 31: | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] | |||
Latest revision as of 02:01, 27 November 2017
|
Hepatosplenic T cell lymphoma Microchapters |
|
Differentiating Hepatosplenic T cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatosplenic T cell lymphoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma medical therapy |
|
Directions to Hospitals Treating Hepatosplenic T cell lymphoma |
|
Risk calculators and risk factors for Hepatosplenic T cell lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The predominant therapy for hepatosplenic T cell lymphoma is chemotherapy. Adjunctive stem cell transplant may be required.
Medical Therapy
The predominant therapy for hepatosplenic T cell lymphoma is chemotherapy. Adjunctive stem cell transplant may be required.
| Therapy | Description |
|---|---|
| Chemotherapy |
|
| Stem cell transplant |
|
References
- ↑ Hepatosplenic T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/hepatosplenic-t-cell-lymphoma/?region=nb. Accessed on February 23, 2016